Essetifin SPA 13D and 13G filings for RegeneRx Biopharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-07-06 4:35 pm Purchase | 2023-07-03 | 13D | RegeneRx Biopharmaceuticals, Inc. RGRX | Essetifin SPA | 6,040 36.100% | 513 (+9.27%) | Filing |
| 2021-07-02 4:15 pm Purchase | 2021-06-30 | 13D | RegeneRx Biopharmaceuticals, Inc. RGRX | Essetifin SPA | 5,527 34.100% | 375 (+7.28%) | Filing |
| 2020-10-16 4:16 pm Purchase | 2020-10-15 | 13D | RegeneRx Biopharmaceuticals, Inc. RGRX | Essetifin SPA | 5,152 34.400% | 195 (+3.93%) | Filing |